Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,087B 11.43B 10.22B 9.45B 8.56B 16.02B 16.28B 114B 45B 569B 42.89B 41.97B 1,800B P/E 2027 *
29.1x
P/E 2028 * 22.3x
Enterprise Value 1,059B 11.14B 9.96B 9.21B 8.34B 15.61B 15.87B 111B 43.85B 554B 41.79B 40.9B 1,754B EV / Sales 2027 *
3.02x
EV / Sales 2028 * 2.63x
Free-Float
69.73%
Yield 2027 *
0.57%
Yield 2028 * 0.64%
1 day+0.18%
1 week+3.96%
Current month+9.23%
1 month+10.19%
3 months+17.12%
6 months-1.32%
Current year-1.82%
1 week 13.06
Extreme 13.055
13.86
1 month 11.99
Extreme 11.99
13.86
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 02/04/2013
Chairman 58 13/05/2014
Director/Board Member 66 31/01/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%+3.96% - - 11.41B
+0.38%-0.13%+55.13%+128.84% 1,140B
+0.36%+2.99%+40.37%+83.46% 641B
-0.14%-0.86%+25.69%+106.29% 507B
+0.63%+2.33%+49.21%+67.82% 383B
+0.94%-4.23%+61.40%+38.13% 347B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 266B
+0.67%+2.00%+53.77%+71.17% 240B
-0.43%+0.96%+31.16%+106.23% 197B
Average +0.31%+2.92%+38.20%+75.82% 445.98B
Weighted average by Cap. +0.34%+2.98%+42.06%+88.27%

Financials

2027 *2028 *
Net sales 351B 3.69B 3.3B 3.06B 2.77B 5.18B 5.26B 36.76B 14.54B 184B 13.86B 13.56B 582B 393B 4.14B 3.7B 3.42B 3.1B 5.8B 5.89B 41.17B 16.29B 206B 15.52B 15.19B 652B
Net income 37.06B 390M 348M 322M 292M 546M 555M 3.88B 1.53B 19.38B 1.46B 1.43B 61.37B 49.23B 517M 463M 428M 388M 725M 737M 5.15B 2.04B 25.75B 1.94B 1.9B 81.54B
Net Debt -27.73B -291M -261M -241M -218M -409M -415M -2.9B -1.15B -14.51B -1.09B -1.07B -45.93B -51.33B -540M -482M -446M -404M -756M -769M -5.37B -2.12B -26.85B -2.02B -1.98B -85.01B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
27/10/26 $13.79 +0.25% 2,258,428
26/10/26 $13.75 +4.09% 4,121,883
23/10/26 $13.21 -0.15% 3,909,244
22/10/26 $13.23 +0.30% 3,983,257
21/10/26 $13.19 -0.53% 2,114,079
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,305.00INR
Average target price
1,357.05INR
Spread / Average Target
+3.99%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited